| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/27/2002 | EP1260585A1 Novel protein and gene encoding the same |
| 11/27/2002 | EP1260584A1 Novel protein having signal sequence |
| 11/27/2002 | EP1260583A1 System and method for manipulating magnetically responsive particles in fluid samples to collect DNA or RNA from a sample |
| 11/27/2002 | EP1260521A2 Immunoglobulin variants for specific Fc epsilon receptors |
| 11/27/2002 | EP1260520A2 Chromosome 13-linked breast cancer susceptibility gene |
| 11/27/2002 | EP1260519A1 Membrane receptors for steroids and sterols |
| 11/27/2002 | EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses |
| 11/27/2002 | EP1259946A2 Cellular telephone interactive wagering system |
| 11/27/2002 | EP1259819A2 Diagnosis of bipolar affective disorder (bad) and unipolar depression |
| 11/27/2002 | EP1259813A2 Diagnosis and treatment of malignant neoplasms |
| 11/27/2002 | EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 11/27/2002 | EP1259808A2 Method for labeling individual cells |
| 11/27/2002 | EP1259650A2 Estrogen receptor alpha variants and methods of detection thereof |
| 11/27/2002 | EP1259648A2 Diagnostics and therapeutics for glaucoma |
| 11/27/2002 | EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 11/27/2002 | EP1259646A2 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 11/27/2002 | EP1259645A1 Universal variable fragments |
| 11/27/2002 | EP1259644A2 Novel dna chips |
| 11/27/2002 | EP1259643A2 Nucleic acid detection methods using universal priming |
| 11/27/2002 | EP1259642A1 Nucleic acids, proteins, and antibodies |
| 11/27/2002 | EP1259640A2 Methods and compositions for the screening of cell cycle modulators |
| 11/27/2002 | EP1259629A2 Recombinant influenza a viruses |
| 11/27/2002 | EP1259628A1 Methods for generating hypermutable yeast |
| 11/27/2002 | EP1259627A2 Heterologous expression of neisserial proteins |
| 11/27/2002 | EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators |
| 11/27/2002 | EP1259625A2 18232, a dual specificity phosphatase |
| 11/27/2002 | EP1259624A2 Thermostable chimeric nucleic acid polymerases and uses thereof |
| 11/27/2002 | EP1259623A2 Aspartate carbamyltransferase as herbicidal target |
| 11/27/2002 | EP1259622A2 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 11/27/2002 | EP1259621A2 Lipid metabolism enzymes |
| 11/27/2002 | EP1259620A2 2504, 15977, and 14760, novel protein kinase family members and uses therefor |
| 11/27/2002 | EP1259619A2 Variant galactose oxidase, nucleic acid encoding same, and methods of using same |
| 11/27/2002 | EP1259618A2 Human enzyme molecules |
| 11/27/2002 | EP1259617A2 Bunyaviridal reaper proteins and uses therefor |
| 11/27/2002 | EP1259616A2 Tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 11/27/2002 | EP1259615A1 Human antibodies against eotaxin and their use |
| 11/27/2002 | EP1259614A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/27/2002 | EP1259613A2 Human proteins and polynucleotides encoding the same |
| 11/27/2002 | EP1259612A2 G-protein coupled receptor related polypeptides |
| 11/27/2002 | EP1259611A2 G-protein coupled receptors |
| 11/27/2002 | EP1259610A2 Human transporter proteins and polynucleotides encoding the same |
| 11/27/2002 | EP1259609A2 Human schizophrenia gene |
| 11/27/2002 | EP1259608A1 Modified fluorescent proteins |
| 11/27/2002 | EP1259606A2 Compositions useful for regulating parkin gene activity |
| 11/27/2002 | EP1259605A2 Mutated cyclin g1 protein |
| 11/27/2002 | EP1259604A1 Bcmp 84, a protein associated to breast cancer |
| 11/27/2002 | EP1259603A2 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 11/27/2002 | EP1259602A1 Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same |
| 11/27/2002 | EP1259601A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 11/27/2002 | EP1259600A2 Gene targeting method |
| 11/27/2002 | EP1259599A1 Cell fusion assays using fluorescence resonance energy transfer |
| 11/27/2002 | EP1259597A2 Zinc finger domains and methods of identifying same |
| 11/27/2002 | EP1259595A2 Integrin antagonists |
| 11/27/2002 | EP1259590A2 Method for transferring material in a cell system |
| 11/27/2002 | EP1259547A2 High potency recombinant antibodies and method for producing them |
| 11/27/2002 | EP1259546A1 Ccr2-64i, polymorphic variant of the human ccr2 receptor and its use in the diagnostic and treatment of atherosclerosis |
| 11/27/2002 | EP1259544A2 Heterologous polypeptide of the tnf family |
| 11/27/2002 | EP1259542A2 Reagents and methods useful for detecting diseases of the breast |
| 11/27/2002 | EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 11/27/2002 | EP1259540A1 Nucleic acids, proteins, and antibodies |
| 11/27/2002 | EP1259539A1 Diagnosis and treatment of bipolar affective disorder |
| 11/27/2002 | EP1259537A1 Gene expression system based on chimeric receptors |
| 11/27/2002 | EP1259531A2 Nucleic acids, proteins, and antibodies |
| 11/27/2002 | EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 11/27/2002 | EP1259529A2 Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 11/27/2002 | EP1259528A1 Nucleic acids, proteins and antibodies |
| 11/27/2002 | EP1259527A1 35 human secreted proteins |
| 11/27/2002 | EP1259526A2 Nucleic acids, proteins, and antibodies |
| 11/27/2002 | EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 11/27/2002 | EP1259524A2 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage |
| 11/27/2002 | EP1259324A2 Multiple-site reaction device and method |
| 11/27/2002 | EP1259322A1 Polymeric anion exchanger resins and their use in chromatographic methods |
| 11/27/2002 | EP1259265A2 Nucleic acid formulations for gene delivery and methods of use |
| 11/27/2002 | EP1259264A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 11/27/2002 | EP1259263A1 Complexation of rna, especially ribozymes, with polyethylenimines for the stabilization and cellular introduction thereof |
| 11/27/2002 | EP1259258A1 Gm-negative ehv-mutants |
| 11/27/2002 | EP1259256A1 Antigenic complexes and methods |
| 11/27/2002 | EP1259254A1 Method of treatment of anorectal disorders |
| 11/27/2002 | EP1259253A2 Methods for promoting production of myelin by schwann cells |
| 11/27/2002 | EP1259251A2 Novel method for down-regulation of amyloid |
| 11/27/2002 | EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4) |
| 11/27/2002 | EP1246649A4 Intravascular delivery of nucleic acid |
| 11/27/2002 | EP1180164A4 Methods using of fab i and compounds modulating fab i activity |
| 11/27/2002 | EP1078256B1 Process for evaluating chemical and biological assays |
| 11/27/2002 | EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 11/27/2002 | EP1019504A4 Isoforms of the human vitamin d receptor |
| 11/27/2002 | EP0970249B1 Method for detecting mutated allels |
| 11/27/2002 | EP0938551A4 Ku DEFICIENT CELLS AND NON-HUMAN TRANSGENIC ANIMALS |
| 11/27/2002 | EP0935678A4 METHODS FOR TREATING BIPOLAR MOOD DISORDER ASSOCIATED WITH MARKERS ON CHROMOSOMES 18p |
| 11/27/2002 | EP0934331B1 Mirror-symmetrical selection and evolution of nucleic acids |
| 11/27/2002 | EP0804210B1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells |
| 11/27/2002 | EP0776331B1 Higher order structure and binding of peptide nucleic acids |
| 11/27/2002 | EP0717780B1 Detection and speciation of campylobacter |
| 11/27/2002 | EP0700402B1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 11/27/2002 | EP0675961B1 Treatment of tumorigenic disease with a modified HSV |
| 11/27/2002 | EP0632831B1 Nucleic acid, expressionvector and compositions for the identification and synthesis of recombinant sialyltransferases |
| 11/27/2002 | EP0630409B1 Defective packaging non-oncoviral vectors based on mpmv |
| 11/27/2002 | EP0608261B1 Immunoreactive hepatitis c virus polypeptide compositions |
| 11/27/2002 | EP0585267B1 Herpesvirus particle preparation and vaccine |
| 11/27/2002 | CN1382259A Improved method for detection of acid resistant microorganisms in stool |